Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease
Journal of Kidney Cancer and VHL · 05.08.2014 · 1 (4) · 46-55
DOI: 10.15586/jkcvhl.2014.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Kidney Cancer and VHL, online erschienen am 05.08.2014. Verfasst von Hiroshi Kanno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yokohama City University School of Medicine; Department of Neurosurgery, Yokosuka City Hospital, Yokosuka, Japan. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Central nervous system (CNS) hemangioblastoma is the most common manifestation of von Hippel-Lindau (VHL) disease. It is found in 70-80% of VHL patients. Hemangioblastoma is a rare form of benign vascular tumor of the CNS, accounting for 2.0% of CNS tumors. It can occur sporadically or as a familial syndrome. CNS hemangioblastomas are typically located in the posterior fossa and the spinal cord. VHL patients usually develop a CNS hemangioblastoma at an early age. Therefore, they require a special routine for diagnosis, treatment and follow-up. The surgical management of symptomatic tumors depend on many factors such as symptom, location, multiplicity, and progression of the tumor. The management of asymptomatic tumors in VHL patients are controversial since CNS hemangioblastomas grow with intermittent quiescent and rapid-growth phases. Preoperative embolization of large solid hemangioblastomas prevents perioperative hemorrhage but is not necessary in every case. Radiotherapy should be reserved for inoperable tumors. Because of complexities of VHL, a better understanding of the pathological and clinical features of hemangioblastoma in VHL is essential for its proper management.
Autor:innen und Institutionen
- Department of Neurosurgery, Yokohama City University School of Medicine; Department of Neurosurgery, Yokosuka City Hospital, Yokosuka, Japan.
Zitieren
APA
Kanno, H., Kobayashi, N., & Nakanowatari, S. (2014). Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease. Journal of Kidney Cancer and VHL, 1(4), 46-55. https://doi.org/10.15586/jkcvhl.2014.12
Vancouver
Kanno H, Kobayashi N, Nakanowatari S. Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease. Journal of Kidney Cancer and VHL. 2014;1(4):46-55. doi:10.15586/jkcvhl.2014.12
BibTeX
@article{Kanno2014,
author = {Kanno, Hiroshi and Kobayashi, Natsuki and Nakanowatari, Satoshi},
title = {Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease},
journal = {Journal of Kidney Cancer and VHL},
year = {2014},
volume = {1},
number = {4},
pages = {46--55},
doi = {10.15586/jkcvhl.2014.12}
}
EUVIMED